Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNationwide Ccds Regulatory News (NBS)

Share Price Information for Nationwide Ccds (NBS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 133.00
Bid: 130.00
Ask: 136.00
Change: 0.00 (0.00%)
Spread: 6.00 (4.615%)
Open: 133.00
High: 133.00
Low: 133.00
Prev. Close: 133.00
NBS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Result of Tender Offer

23 Feb 2023 15:43

RNS Number : 8980Q
Nationwide Building Society
23 February 2023
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN (1) THE UNITED STATES, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OR THE DISTRICT OF COLUMBIA (THE UNITED STATES), (2) THE REPUBLIC OF ITALY, OR (3) ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

Nationwide Building Society announces final results of

its inaugural Open Market Repurchase Exercise

in respect of its Core Capital Deferred Shares

23 February 2023.  On 20 February 2023, Nationwide Building Society (Nationwide) announced (i) the launch of an open market repurchase facility (the OMR Facility) under which it may, from time to time and in its sole discretion, seek to repurchase limited numbers of the Core Capital Deferred Shares of £1 nominal amount each (ISIN: GB00BBQ33664) (the CCDS) issued by Nationwide and (ii) the commencement of the inaugural open market repurchase exercise under the OMR Facility (the OMR Exercise 2023-1).

The OMR Exercise 2023-1 was made on the terms and subject to the conditions contained in the announcement made by Nationwide on 20 February 2023 (the Launch Announcement). Capitalised terms used, but not defined, in this announcement have the meanings given to them in the Launch Announcement.

The Second OMR Tender Period expired at 3.00 p.m. (London time) on 23 February 2023, and Nationwide announces today the final results of the OMR Exercise 2023-1.

Final Results of OMR Exercise 2023-1

Nationwide announces that it has decided to set the Second OMR Acceptance Amount at 387,804 CCDS, and that Nationwide will accordingly accept for purchase CCDS validly tendered during the Second OMR Tender Period subject to application of a Scaling Factor of 65.01 per cent., as described in the Launch Announcement.

The expected settlement date for CCDS validly tendered during, and accepted for purchase in connection with, the Second OMR Tender Period is 27 February 2023 (the Second OMR Settlement Date).

On the Second OMR Settlement Date, holders of CCDS validly tendered for purchase during the Second OMR Tender Period and accepted for purchase will receive, for each CCDS purchased, an amount equal to the aggregate of (i) the Purchase Price of £128.93 per CCDS and (ii) an Amount Attributable to Potential Future Distributions of £1.94 per CCDS.

Following settlement on the Second OMR Settlement Date, Nationwide will have purchased an aggregate of 775,608 CCDS pursuant to the OMR Exercise 2023-1. Nationwide intends to hold all such CCDS purchased by it pursuant to the OMR Exercise 2023-1 in treasury, and future re-sales of any purchased CCDS may occur from time to time at the sole discretion of Nationwide. The Conditions of the CCDS provide that any such re-sale will not be subject to pre-emption rights.

Summary

Description of the CCDS

ISIN

Second OMR Acceptance Amount

Scaling Factor

Aggregate number of CCDS purchased by Nationwide pursuant to the OMR Exercise 2023-1

Aggregate number of CCDS outstanding following the OMR Exercise 2023-1

Nationwide's Core Capital Deferred Shares of £1 nominal amount each

GB00BBQ33664

387,804 CCDS

65.01 per cent.

775,608 CCDS

9,779,892 CCDS*

* This figure excludes the CCDS purchased by Nationwide pursuant to the OMR Exercise 2023-1, which (for so long as they are held by Nationwide in treasury) will be deemed not to be outstanding for certain purposes under the Conditions of the CCDS.

UBS AG London Branch (Telephone: +44 20 7568 1121; Attention: Liability Management Group; Email: ol-liabilitymanagement-eu@ubs.com) is acting as Dealer Manager in connection with the OMR Exercise 2023-1.

LEI of Nationwide Building Society: 549300XFX12G42QIKN82

DISCLAIMER

This announcement must be read together with the Launch Announcement. No offer or invitation to acquire any securities is being made pursuant to this announcement.

The distribution of this announcement and the Launch Announcement in certain jurisdictions may be restricted by law. Persons into whose possession this announcement and/or the Launch Announcement come(s) are required by Nationwide and the Dealer Manager to inform themselves about, and to observe, any such restrictions.

The OMR Exercise 2023-1 has now expired and no additional CCDS will be accepted for purchase pursuant to the OMR Exercise 2023-1.

This announcement is made by Nationwide, and the Dealer Manager does not accept any responsibility for the contents of this announcement.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RTEDZGZZKFZGFZM
Date   Source Headline
5th Aug 20222:47 pmRNSPublication of Final Terms
5th Aug 20222:46 pmRNSPublication of Final Terms
26th Jul 20222:53 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
20th Jul 20223:22 pmRNSPublication of Final Terms
14th Jul 20223:43 pmRNSResult of AGM
12th Jul 20229:29 amRNSPre Stabilisation Notice - Nationwide Building Soc
24th Jun 202210:45 amRNSPublication of a Prospectus
10th Jun 20227:30 amRNSResolvability Assessment Framework
9th Jun 20224:56 pmRNSFurther re Tender Offer
25th May 20223:01 pmRNSTender Offer
20th May 202212:44 pmRNSPublication of Supplemental Prospectus
20th May 20227:00 amRNSAnnual Financial Report
16th May 20222:21 pmRNSPublication of Final Terms
26th Apr 20226:00 pmRNSPublication of Final Terms
5th Apr 20224:10 pmRNSRedemption of Notes
1st Apr 20229:00 amRNSDirectorate Change
1st Mar 20229:00 amRNSBoard Changes
25th Feb 20223:19 pmRNSPublication of a Prospectus
15th Feb 20229:23 amRNSPublication of Final Terms
15th Feb 20229:23 amRNSPublication of Final Terms
28th Jan 20228:00 amRNSBoard Changes
14th Dec 20217:00 amRNSResponse to Results of BoE Stress Test 2021
10th Dec 20211:51 pmRNSPublication of Base Prospectus
10th Dec 20211:41 pmRNSPublication of Base Prospectus
3rd Dec 20218:00 amRNSLeadership Succession
19th Nov 202111:13 amRNSPublication of Suppl.Prospcts
19th Nov 20217:00 amRNSHalf-year Report
29th Oct 20213:34 pmRNSPublication of a Prospectus
19th Oct 20217:00 amRNSPermanent Interest Bearing Shares Call Notice
11th Oct 20214:23 pmRNSPublication of Final Terms
23rd Sep 20219:00 amRNSLeadership Succession
10th Sep 20215:36 pmRNSPublication of Final Terms
22nd Jul 20212:49 pmRNSResults of AGM and Board changes
7th Jul 20211:57 pmRNSResult of Meeting
29th Jun 202112:15 pmRNSPublication of a Base Prospectus
3rd Jun 202111:00 amRNSCirc re. Notice of Meeting
3rd Jun 202110:59 amRNSTender Offer and Consent Solicitation
24th May 20211:53 pmRNSPublication of Suppl.Prospcts
21st May 20217:00 amRNSAnnual Financial Report
5th May 20212:06 pmRNSPublication of Final Terms
1st Apr 20219:46 amRNSPublication of Suppl.Prospcts
1st Mar 20216:05 pmRNSPublication of Final Terms
1st Mar 20211:00 pmRNSAppointment of Non-Executive Director
12th Feb 20216:03 pmRNSPublication of a Prospectus
22nd Jan 202110:39 amRNSPublication of Final Terms
7th Jan 202112:32 pmRNSPublication of a Prospectus
16th Dec 202010:33 amRNSPublication of Final Terms
8th Dec 202012:47 pmRNSHolding(s) in Company
8th Dec 202012:46 pmRNSInitial admission - Offcl Lst

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.